Alina O. Godzoyeva
Research Subjects
Alina O. Godzoyeva has a total of 60 co-authors. Here are the top co-authors by number of shared publications:
- Irina E. Zazerskaya
Almazov National Medical Research Centre
3 shared publications - Tatyana V. Vavilova
Almazov National Medical Research Center
2 shared publications - Albina I. Dukovich
V.A. Almazov National Medical Research Center
1 shared publication - Alina Yur'EVna Babenko
Almazov National Medical Research Center
1 shared publication - Anna A. Kuznetsova
Almazov National Medical Research Centre
1 shared publication - Anna Alekseyevna Tsypurdeyeva
The Research Institute of Obstetrics, Gynecology and Reproductology named after D.O. Ott
1 shared publication
Latest Publications
- 1 January 2025
- Published by ECO-Vector LLC (Publications)
Clinical Pharmacology Handbook for Obstetricians and Gynecologists. Edited by Irina E. Zazerskaya, Mikhail V. Pchelintsev, Andrei N. Kubynin
This clinical pharmacology handbook is organized according to the nosological principle of the ICD-10 classification and contains information on the necessary diagnostic and pharmacotherapeutic measures for conditions encountered in obstetric and gynecological practice. The book describes the drugs that are approved in the Russian Federation. The systematic organization of this large body of material allows the physician to easily determine a diagnostic and treatment plan based on current guidelines, select a drug by its international nonproprietary or brand name, verify its dosage, route of administration, and therapy duration, and provide a prescription. The handbook is intended for obstetricians and gynecologists to use in their daily practice. It will also be helpful to continuing education students at the departments of obstetrics and gynecology and clinical pharmacology.
- 1 January 2025
- Published by ECO-Vector LLC (Publications)
Clinical Pharmacology Handbook for Obstetricians and Gynecologists. Edited by Irina E. Zazerskaya, Mikhail V. Pchelintsev, Andrei N. Kubynin
This clinical pharmacology handbook is organized according to the nosological principle of the ICD-10 classification and contains information on the necessary diagnostic and pharmacotherapeutic measures for conditions encountered in obstetric and gynecological practice. The book describes the drugs that are approved in the Russian Federation. The systematic organization of this large body of material allows the physician to easily determine a diagnostic and treatment plan based on current guidelines, select a drug by its international nonproprietary or brand name, verify its dosage, route of administration, and therapy duration, and provide a prescription. The handbook is intended for obstetricians and gynecologists to use in their daily practice. It will also be helpful to continuing education students at the departments of obstetrics and gynecology and clinical pharmacology.
- 15 April 2022
- Published by ECO-Vector LLC in Journal of obstetrics and women's diseases
- Vol. 71 (2) , 39-48
Prognostic value of sFlt-1 and PlGF in the diagnosis of abnormally deep placental invasion
BACKGROUND: Placental adhesive disorder is associated with a high risk of massive bleeding during pregnancy and caesarean delivery. Abnormal trophoblast invasion and pathological hypervascularization detected in these patients may be due to the imbalance of angiogenic factors such as PlGF and sFlt-1, which makes their study an important area of scientific and clinical practice. AIM: The aim of this study was to evaluate sFlt-1 and PlGF levels in women with placenta accrete spectrum and to compare the data with the results in women with normal pregnancy. MATERIALS AND METHODS: This case-control study included 71 pregnant women in the third trimester of pregnancy. The main group (n = 32) consisted of patients with prenatally diagnosed placenta previa and abnormally invasive placenta; the control group (n = 39) included patients with normal pregnancy. In the study groups, the levels of sFlt-1 and PlGF were determined, with ultrasound and MRI characteristics evaluated. Statistical analysis was performed using IBM SPSS Statistics 26.0. RESULTS: Serum sFlt-1 and PlGF levels in the study group differed as compared to controls. In women with placenta accreta spectrum, the median sFlt-1 level was 2886.0 [2175.04127.0] pg/ml vs. control: 1890.0 [1807.02205.0] pg/ml (р 0.001); the median PlGF level was 233.5 [171.4460.5] pg/ml vs. control: 880.9 [746.61210.0] pg/ml (p 0.001). A correlation was revealed between the angiogenic factor levels and the degree of pathological hypervascularization and collaterization according to MRI data. When comparing the probability of abnormally invasive placenta (PAS Grades 2 or 3) and the sFlt-1/PlGF ratio, an ROC curve was obtained with the AUC of 0.74 0.13 (95% CI: 0.481.0; p = 0.021). CONCLUSIONS: Patients with placental adhesive disorder had increased sFlt-1 levels and decreased PlGF levels compared to patients with normal pregnancy. The above levels correlated with the degree of pathological hypervascularization and collaterization detected by MRI. A prognostic model has been obtained, according to which the threshold value of the sFlt-1/PlGF ratio of 4.22 allows for distinguishing patients with deep placental invasion (PAS Grades 2 or 3).
- 15 April 2022
- Published by ECO-Vector LLC in Journal of obstetrics and women's diseases
- Vol. 71 (2) , 39-48
Prognostic value of sFlt-1 and PlGF in the diagnosis of abnormally deep placental invasion
BACKGROUND: Placental adhesive disorder is associated with a high risk of massive bleeding during pregnancy and caesarean delivery. Abnormal trophoblast invasion and pathological hypervascularization detected in these patients may be due to the imbalance of angiogenic factors such as PlGF and sFlt-1, which makes their study an important area of scientific and clinical practice. AIM: The aim of this study was to evaluate sFlt-1 and PlGF levels in women with placenta accrete spectrum and to compare the data with the results in women with normal pregnancy. MATERIALS AND METHODS: This case-control study included 71 pregnant women in the third trimester of pregnancy. The main group (n = 32) consisted of patients with prenatally diagnosed placenta previa and abnormally invasive placenta; the control group (n = 39) included patients with normal pregnancy. In the study groups, the levels of sFlt-1 and PlGF were determined, with ultrasound and MRI characteristics evaluated. Statistical analysis was performed using IBM SPSS Statistics 26.0. RESULTS: Serum sFlt-1 and PlGF levels in the study group differed as compared to controls. In women with placenta accreta spectrum, the median sFlt-1 level was 2886.0 [2175.04127.0] pg/ml vs. control: 1890.0 [1807.02205.0] pg/ml (р 0.001); the median PlGF level was 233.5 [171.4460.5] pg/ml vs. control: 880.9 [746.61210.0] pg/ml (p 0.001). A correlation was revealed between the angiogenic factor levels and the degree of pathological hypervascularization and collaterization according to MRI data. When comparing the probability of abnormally invasive placenta (PAS Grades 2 or 3) and the sFlt-1/PlGF ratio, an ROC curve was obtained with the AUC of 0.74 0.13 (95% CI: 0.481.0; p = 0.021). CONCLUSIONS: Patients with placental adhesive disorder had increased sFlt-1 levels and decreased PlGF levels compared to patients with normal pregnancy. The above levels correlated with the degree of pathological hypervascularization and collaterization detected by MRI. A prognostic model has been obtained, according to which the threshold value of the sFlt-1/PlGF ratio of 4.22 allows for distinguishing patients with deep placental invasion (PAS Grades 2 or 3).
- Open Access
- 28 September 2020
- Published by ECO-Vector LLC in Journal of obstetrics and women's diseases
- Vol. 69 (4) , 29-40
Pneumonia in pregnant women with COVID-19: is it a new thrombotic microangiopathy in obstetric practice?
Thrombotic microangiopathies during pregnancy and puerperium are rare and, if undiagnosed, can be life-threating conditions for both the mother and the baby. The aim of this review article is to briefly describe clinical profile and highlight the clues for a correct diagnosis of pregnancy-related thrombotic microangiopathies. Of particular interest and important practical significance are the presented data on changes in the hemostatic system in patients with a new coronavirus infection COVID-19 through the prism of thrombotic microangiopathies.
- 28 September 2020
- Published by ECO-Vector LLC in Journal of obstetrics and women's diseases
- Vol. 69 (4) , 29-40
Open AccessPneumonia in pregnant women with COVID-19: is it a new thrombotic microangiopathy in obstetric practice?
Thrombotic microangiopathies during pregnancy and puerperium are rare and, if undiagnosed, can be life-threating conditions for both the mother and the baby. The aim of this review article is to briefly describe clinical profile and highlight the clues for a correct diagnosis of pregnancy-related thrombotic microangiopathies. Of particular interest and important practical significance are the presented data on changes in the hemostatic system in patients with a new coronavirus infection COVID-19 through the prism of thrombotic microangiopathies.